Rahul Kakkar is the founder of Tome Biosciences. Tome Biosciences has raised $213M in total funding. Latest round: Series B.
Rahul Kakkar is the CEO of Tome Biosciences, a Watertown, Massachusetts-based biotech company focused on programmable genomic integration (PGI) technology. He joined the company in August 2021, after it was founded in February 2021, and led the closure of its first Series A round before advancing toward a Series B to prove the technology prior to patient trials. Across his prior companies, Kakkar has led fundraising totaling over $300M.
Full founder directory · Investor directory · Company funding database · Fundraising library